Lung cancer epidemic has not ended. According to the data on the incidence and mortality in the Czech Republic it is obvious that both parameters decline in males; the rise in women probably ends. According to the present epidemiological parameters the number of new cases is still very high. Number of adenocarcinomas is slightly rising. No improvement has been achieved in the early diagnostics of TNM stage I and II, which are diagnosed in less than 21 %. It brings low number of indications for resection therapy, which in 2003 achieved 10.8 % for men and 10.1 % for women. Positive appears the higher number of verified tumours (72 % in men and 69 % in women) and the higher percentage of those who survived over 5 years (6.3 % in men and 9.4 % in women) in comparison with the situation 10 years earlier. The presented paper describes regional differences in the incidence of lung carcinoma (apparent gradient between the western and eastern part of the country) and the promptness of the diagnostics and the treatment indications.

        Key words: lung cancer, adenocarcinoma, non-resection therapy.